Response to Drs Rogers, Hayes, and Demanes - PubMed (original) (raw)

Comment

. 2014 Sep-Oct;13(5):523-5.

doi: 10.1016/j.brachy.2014.05.007. Epub 2014 May 28.

Yoshiya Yamada 2, Dean G Assimos 3, Anthony V D'Amico 4, Brian J Davis 5, Steven J Frank 6, Alexander R Gottschalk 1, Gary S Gustafson 7, Patrick W McLaughlin 8, Paul L Nguyen 9, Seth A Rosenthal 10, Al V Taira 11, Neha Vapiwala 12, Gregory Merrick 13; Expert Panel on Radiation Oncology–Prostate

Affiliations

• PMID: 24880587
• DOI: 10.1016/j.brachy.2014.05.007

Comment

Response to Drs Rogers, Hayes, and Demanes

I-Chow Joe Hsu et al. Brachytherapy. 2014 Sep-Oct.

No abstract available

PubMed Disclaimer

Comment on

• ACR Appropriateness Criteria high-dose-rate brachytherapy for prostate cancer.
  Hsu IC, Yamada Y, Assimos DG, D'Amico AV, Davis BJ, Frank SJ, Gottschalk AR, Gustafson GS, McLaughlin PW, Nguyen PL, Rosenthal SA, Taira AV, Vapiwala N, Merrick G. Hsu IC, et al. Brachytherapy. 2014 Jan-Feb;13(1):27-31. doi: 10.1016/j.brachy.2013.11.007. Epub 2013 Dec 22. Brachytherapy. 2014. PMID: 24368283 Review.
• A critical ACR appropriateness Criteria omission.
  Rogers L, Hayes J, Demanes DJ. Rogers L, et al. Brachytherapy. 2014 Sep-Oct;13(5):522-3. doi: 10.1016/j.brachy.2014.05.002. Epub 2014 Jun 10. Brachytherapy. 2014. PMID: 24927922 No abstract available.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • ClinicalKey
  • Elsevier Science

• Other Literature Sources

  • scite Smart Citations

• Medical

  • MedlinePlus Health Information